More News

18 Jan 2017 Takeda and Ovid Therapeutics Announce Innovative Clinical Development and Commercialization Collaboration for TAK-935 in Rare Pediatric Epilepsies
18 Jan 2017 Lilly and CoLucid Pharmaceuticals Announce Agreement for Lilly To Acquire CoLucid
18 Jan 2017 Biogen and Forward Pharma Agree to Enter into Settlement and License Agreement
16 Jan 2017 WILEX signs antibody license agreement with Telix Pharmaceuticals Limited
13 Jan 2017 Kitov Enters Immuno-Oncology Field Through Acquisition of TyrNovo
12 Jan 2017 PIQUR and PIERRE FABRE Announce Partnership in Dermato-Oncology
12 Jan 2017 Maverick Therapeutics and Takeda Announce Five-year Collaboration to Advance T-Cell Engagement Therapies
12 Jan 2017 Merck KGaA, Darmstadt, Germany Licenses Four Oncology Research and Development Programs from Vertex
12 Jan 2017 Lilly and Merck Expand Immuno-Oncology Collaboration
11 Jan 2017 Kite Pharma and Fosun Pharma Establish Joint Venture in China to Develop and Commercialize Autologous T-Cell Therapies to Treat Cancer
11 Jan 2017 Sarepta Therapeutics Enters into License Agreement with Nationwide Children’s Hospital for Galgt2 Gene Therapy Program
11 Jan 2017 Sarepta Therapeutics Enters into Research Agreement and Option Agreement with Nationwide Children’s Hospital for Microdystrophin Gene Therapy Program
11 Jan 2017 LegoChem Biosciences Enters into Research Licensing Agreement with Takeda to Develop Next-Generation Antibody-Drug Conjugate Candidates
11 Jan 2017 University of Pittsburgh and Bayer Form Alliance to Advance Research for New Therapies for Heart, Lung and Blood Diseases
11 Jan 2017 ZIOPHARM and Intrexon Announce Cooperative Research and Development Agreement with the National Cancer Institute Utilizing Sleeping Beauty System to Generate T cells Targeting Neoantigens
10 Jan 2017 Moderna Provides Pipeline and Full-Year Corporate Update
10 Jan 2017 Daiichi Sankyo Establishes Strategic Partnership for Cellular Therapy Pipeline with Kite Pharma
09 Jan 2017 Sanofi and ImmuNext Enter into Agreement to Develop Treatments for Autoimmune Diseases
09 Jan 2017 Ferring Partners with Intralytix to Develop Bacteriophage Treatments for Conditions Associated with the Microbiome and Drug-Resistant Bacteria
09 Jan 2017 AbbVie Announces Four New Global Research Collaborations Focused on Advancing Next-Generation Science
09 Jan 2017 Anokion Announces Exclusive Strategic Collaboration With Celgene to Develop Novel Tolerance-Inducing Therapeutics for Autoimmune Diseases
09 Jan 2017 AMAG Pharmaceuticals and Palatin Technologies Enter Into Exclusive Licensing Agreement for North American Rights to Rekynda™ (bremelanotide), a Potential Treatment for a Common Female Sexual Disorder
09 Jan 2017 EMD Serono and MD Anderson Cancer Center Enter Three-Year Strategic Collaboration
09 Jan 2017 Takeda to Acquire ARIAD Pharmaceuticals, Inc.
09 Jan 2017 Sierra Oncology Successfully Transfers Sponsorship of SRA737 Clinical Trials

La Merie Biologics

FREE Weekly News Bulletin

2016 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing